Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-18 Sale | 2021-10-20 4:38 pm | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 550,000 | $14.84 | $8,160,736 | 3,245,533 (Indirect Direct) | View |
| 2021-10-18 Sale | 2021-10-20 4:32 pm | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director | 550,000 | $14.84 | $8,160,736 | 64,872 (Indirect Direct) | View |
| 2021-10-18 Sale | 2021-10-20 4:31 pm | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner | 550,000 | $14.84 | $8,160,736 | 3,256,357 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-03 Equity Swap | 2023-01-05 4:30 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 2,768,586 | $0 | 0 (Indirect) | View |
| 2023-01-03 Equity Swap | 2023-01-04 6:11 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 3,657,618 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:16 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Behbahani Ali Director | 24,197 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:14 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. BASKETT FOREST KERINS PATRICK J NEA 14 GP LTD NEA Partners 14 L.P. SANDELL SCOTT D Sonsini Peter W. 10% Owner | 5,925,287 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:10 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director | 47,322 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:08 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director | 10,066 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:08 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director | 14,131 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:08 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Santel Donald J Director | 5,489 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:08 pm | N/A 2031-07-30 | Oyster Point Pharma Inc. | OYST | Santel Donald J Director | 28,727 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:07 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 3,657,618 | $0 | 0 (Indirect) | View |
| 2023-01-03 Disposition | 2023-01-04 5:07 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 25,195 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:06 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 100,738 | $0 | 0 (Direct) | View |
| 2022-01-29 Tax Withholding | 2023-01-04 5:06 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 2,607 | $11.7 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:06 pm | N/A 2032-07-05 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 1,770,003 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:05 pm | N/A 2027-05-24 | Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director | 312,920 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 56,289 | $0 | 0 (Direct) | View |
| 2022-01-29 Tax Withholding | 2023-01-04 5:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 938 | $11.7 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:04 pm | N/A 2032-07-05 | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 737,535 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:03 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director | 39,182 | $0 | 0 (Direct) | View |
| 2023-01-03 Equity Swap | 2023-01-04 5:02 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director | 18,063 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-04 5:02 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director | 19,229 | $0 | 0 (Direct) | View |
| 2022-12-01 Tax Withholding(A) | 2022-12-06 7:05 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 8,938 | $11.2 | 149,660 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-06 08:50 am | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 3,258 | $11.2 | 74,463 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-05 5:36 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 6,217 | $11.2 | 152,381 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:55 pm | N/A 2032-07-05 | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:54 pm | N/A 2032-07-05 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:49 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Behbahani Ali Director | 8,932 | $0 | 18,998 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:49 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 8,932 | $0 | 3,677,614 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:48 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director | 8,932 | $0 | 33,983 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:47 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director | 8,932 | $0 | 42,123 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:46 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director | 8,932 | $0 | 18,998 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:45 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director | 8,932 | $0 | 127,445 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:44 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director | 8,932 | $0 | 32,093 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 4:43 pm | N/A 2032-06-05 | Oyster Point Pharma Inc. | OYST | Santel Donald J Director | 8,932 | $0 | 19,046 (Direct) | View |
| 2022-01-09 Option Award | 2022-01-11 7:47 pm | N/A 2032-01-08 | Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer | 66,600 | $0 | 84,822 (Direct) | View |
| 2022-01-09 Option Award | 2022-01-11 7:46 pm | N/A 2032-01-08 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 256,700 | $0 | 368,598 (Direct) | View |
| 2022-01-09 Option Award | 2022-01-11 7:45 pm | N/A 2032-01-08 | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 107,400 | $0 | 165,621 (Direct) | View |
| 2022-01-05 Other | 2022-01-07 6:08 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director | 6,839 | $0 | 463,993 (Indirect) | View |
| 2022-01-05 Other | 2022-01-07 4:20 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 253,030 | $0 | 3,547,597 (Indirect) | View |
| 2022-01-05 Other | 2022-01-07 4:18 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner | 253,150 | $0 | 3,558,781 (Indirect) | View |
| 2021-12-21 Other | 2021-12-23 5:34 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director | 6,838 | $0 | 665,065 (Indirect) | View |
| 2021-12-21 Other | 2021-12-23 4:43 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner | 253,150 | $0 | 3,559,922 (Indirect) | View |
| 2021-12-21 Other | 2021-12-23 4:40 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 253,030 | $0 | 3,548,858 (Indirect) | View |
| 2021-11-01 Exercise | 2021-11-02 5:49 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 8,590 | $11.51 | 219,472 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 5:49 pm | N/A 2029-07-25 | Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer | 8,590 | $0 | 219,472 (Direct) | View |
| 2021-10-21 Exercise | 2021-10-22 4:41 pm | N/A 2027-11-10 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 50,000 | $0 | 546,672 (Direct) | View |
| 2021-10-21 Exercise | 2021-10-22 4:41 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO | 50,000 | $1.02 | 546,672 (Direct) | View |